ArticleCureus2024
Effects of Adding P2Y12 Inhibitor to Anti-staphylococcal Therapy on Bacterial Clearance in Patients With Staphylococcus aureus Bacteremia.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
background
methodsThis retrospective study involved Japanese patients aged 18 years and older with
resultsDuring the study period, 238 patients with SAB (19 P2Y12 inhibitor users and 219 non-users) were enrolled. The median age was 77 years, and 38.7% of the patients were female individuals. The overall rate of methicillin-resistant
conclusionsThis retrospective study suggests that Japanese patients with SAB using P2Y12 inhibitors prior to admission as adjunctive therapy have a higher rate of microbiological clearance than non-users. However, further prospective studies are needed to determine the benefits of adding P2Y12 inhibitors to standard antimicrobial therapy for SAB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.